After 8 hours, about 28% of one UV filter and 40% of another slowly leaked out of the sunscreen, meaning it releases the active ingredients slowly over time.
Scientific Claim
The NLC-TRF sunscreen released 28% of diethylamino hydroxybenzoyl hexyl benzoate (DHHB) and 40% of ethylhexyl triazone (EHT) cumulatively after 8 hours under in vitro conditions.
Original Statement
“The NLC-TRF sunscreen implies its safety for topical application with sustainable release profile for UV filter (cumulative release of 28% for DHHB and 40% for EHT after 8 h) due to the application of NLCs.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design cannot support claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim reports exact percentages from a direct in vitro measurement. No causal or clinical claims are made. The verb 'released' is appropriate for describing a physical release profile.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1aWhether the 28–40% release profile over 8 hours translates to superior UV protection duration in humans compared to conventional sunscreens.
Whether the 28–40% release profile over 8 hours translates to superior UV protection duration in humans compared to conventional sunscreens.
What This Would Prove
Whether the 28–40% release profile over 8 hours translates to superior UV protection duration in humans compared to conventional sunscreens.
Ideal Study Design
A double-blind RCT with 60 participants applying NLC-TRF or standard sunscreen, measuring persistent UV protection via MED testing every 2 hours for 8 hours post-application under controlled UV exposure.
Limitation: Cannot isolate release profile as the sole factor; skin absorption and sweat may alter outcomes.
Cross-Sectional StudyLevel 3Whether the 28–40% release rate correlates with actual UV filter concentration on skin surface over time.
Whether the 28–40% release rate correlates with actual UV filter concentration on skin surface over time.
What This Would Prove
Whether the 28–40% release rate correlates with actual UV filter concentration on skin surface over time.
Ideal Study Design
A study using tape-stripping and HPLC to measure DHHB and EHT concentration on human skin at 0, 2, 4, 6, and 8 hours after application of NLC-TRF sunscreen in 30 volunteers.
Limitation: Does not measure biological effect or protection; only surface concentration.
In Vitro StudyLevel 4In EvidenceThe rate and extent of UV filter release from the NLC formulation under controlled diffusion conditions.
The rate and extent of UV filter release from the NLC formulation under controlled diffusion conditions.
What This Would Prove
The rate and extent of UV filter release from the NLC formulation under controlled diffusion conditions.
Ideal Study Design
The current study design — using Franz diffusion cells and HPLC to measure cumulative release of DHHB and EHT over 8 hours — is the standard method for in vitro release profiling.
Limitation: Does not account for skin barrier effects, sebum, or environmental factors.
Evidence from Studies
Supporting (1)
In vitro safety evaluation of sunscreen formulation from nanostructured lipid carriers using human cells and skin model.
The scientists tested this specific sunscreen and measured how much of two key ingredients leaked out over 8 hours — and they found exactly the same numbers (28% and 40%) as the claim says.